Soranib (Sorafenib) 200 mg Tablets (120 Count)
Soranib is a premium generic targeted therapy medication. Active ingredient: Sorafenib (200 mg).
Manufacturer: Cipla (India). Cipla is a global pharmaceutical leader, making Soranib one of the most trusted alternatives to Nexavar.
Mechanism:
Soranib is a multikinase inhibitor that targets tumor cell proliferation and angiogenesis (blood vessel formation). By cutting off the tumor's blood supply and blocking internal growth signals, it effectively halts cancer progression.
✅ Quality Assurance: Manufactured under strict GMP standards, ensuring high purity and efficacy.
Approved for the treatment of:
- Advanced Renal Cell Carcinoma (RCC): Kidney cancer.
- Unresectable Hepatocellular Carcinoma (HCC): Liver cancer.
- Differentiated Thyroid Cancer (DTC): Radioactive iodine-refractory thyroid cancer.
Strength: 200 mg tablet.
Recommended Dose: 400 mg (2 tablets) twice daily. Total: 800 mg per day.
⚠️ ADMINISTRATION GUIDE:
Must be taken on an empty stomach (at least 1 hour before or 2 hours after a meal). Taking it with food decreases bioavailability. Swallow whole with water.
- History of cardiac events (myocardial infarction, ischemia).
- Severe hypertension.
- Active bleeding or bleeding disorders.
- Pregnancy and breastfeeding.
- Major surgery (Risk of wound healing complications).
Common adverse reactions:
- Hand-Foot Skin Reaction: Pain, redness, and peeling of palms and soles. Frequent moisturizing is advised.
- Gastrointestinal: Diarrhea, nausea, vomiting.
- Cardiovascular: Hypertension (High blood pressure).
- Fatigue and hair thinning.
What Customers Say
No reviews yet
Your review can be the first!